Free Trial
→ $100 Trillion “AI Metal” Found in American Ghost Town (From Brownstone Research) (Ad) Free TAK Stock Alerts

Takeda Pharmaceutical (TAK) SEC Filings & 10K Form

Takeda Pharmaceutical logo
$14.46 +0.10 (+0.70%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$14.45 -0.01 (-0.07%)
As of 08/8/2025 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Takeda Pharmaceutical SEC Filings

Export to Excel
DateFilerForm TypeView
08/07/2025
7:51 PM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
07/31/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2025
5:02 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2025
5:05 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
5:45 AM		Takeda Pharmaceutical (Subject)
Wozniewski Thomas Otto Claus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:29 AM		Ricci Gabriele (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:32 AM		Platford Giles Richard (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:34 AM		Kim Julie So-Young (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:36 AM		Duprey Lauren Rusckowski (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:38 AM		Pignagnoli Agosti Marcello (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:41 AM		Sequeira Ramona (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:43 AM		Bitetti Teresa Marie (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2025
5:17 AM		Amakawa Akiko (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:20 AM		Plump Andrew Stewart (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:23 AM		Takeda Pharmaceutical (Subject)
Weber Christophe Pierre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2025
5:26 AM		Shannon Elaine Mary (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/08/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2025
9:33 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
5:06 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2025
7:26 PM		Takeda Pharmaceutical (Subject)
Form FWP
06/26/2025
8:55 PM		Takeda Pharmaceutical (Filer)
Takeda U.S. Financing Inc. (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
06/26/2025
5:21 AM		Takeda Pharmaceutical (Filer)
Takeda U.S. Financing Inc. (Filer)
Form 424B5
06/25/2025
6:31 AM		Takeda Pharmaceutical (Filer)
Takeda U.S. Financing Inc. (Filer)
Form F-3ASR
06/25/2025
5:23 AM		Takeda Pharmaceutical (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
06/25/2025
5:02 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2025
5:04 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2025
5:08 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2025
5:08 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
5:06 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:27 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:12 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:14 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
5:20 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
5:24 AM		Takeda Pharmaceutical (Filer)
Form SD
Specialized Disclosure Report  
05/12/2025
5:19 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/08/2025
5:14 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Amazon’s big Bitcoin embarrassment (Ad)

Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.

Watch the Bitcoin Skimming strategy here
05/08/2025
5:19 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2025
5:08 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2025
5:12 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2025
5:07 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
5:00 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:46 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:03 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2025
5:40 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
5:28 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
5:33 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
5:06 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2025
5:13 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/12/2025
7:06 AM		Takeda Pharmaceutical (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
01/30/2025
5:24 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:25 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:28 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:29 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
5:23 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
5:07 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
5:00 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:28 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:19 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:21 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
5:01 AM		Takeda Pharmaceutical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/22/2024
7:36 PM		Platford Giles Richard (Reporting)
Takeda Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:TAK) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
National 'Stock Market Reset' Coming September 30 (New WH Order)
Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...
Altimetry | Sponsored
"Death Spiral" Threatening Your Savings
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
Goldco Precious Metals | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...
American Alternative | Sponsored
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored